300 related articles for article (PubMed ID: 15827072)
21. Inhaled insulin: extending the horizons of inhalation therapy.
Guntur VP; Dhand R
Respir Care; 2007 Jul; 52(7):911-22. PubMed ID: 17594734
[TBL] [Abstract][Full Text] [Related]
22. Inhaled human [rDNA origin] insulin, a novel formulation for diabetes mellitus.
Pham DQ; Cohen H; Chu V
J Clin Pharmacol; 2007 Jul; 47(7):890-903. PubMed ID: 17585117
[TBL] [Abstract][Full Text] [Related]
23. Insulin analogues in the management of diabetes.
Vázquez-Carrera M; Silvestre JS
Methods Find Exp Clin Pharmacol; 2004; 26(6):445-61. PubMed ID: 15349139
[TBL] [Abstract][Full Text] [Related]
24. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
[TBL] [Abstract][Full Text] [Related]
25. Inhaled human insulin (Exubera): a review of its use in adult patients with diabetes mellitus.
Dunn C; Curran MP
Drugs; 2006; 66(7):1013-32. PubMed ID: 16740022
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of glargine compared with NPH insulin for the treatment of Type 2 diabetes: a meta-analysis of randomized controlled trials.
Bazzano LA; Lee LJ; Shi L; Reynolds K; Jackson JA; Fonseca V
Diabet Med; 2008 Aug; 25(8):924-32. PubMed ID: 18959605
[TBL] [Abstract][Full Text] [Related]
27. Novel insulins: expanding options in diabetes management.
Gerich JE
Am J Med; 2002 Sep; 113(4):308-16. PubMed ID: 12361817
[TBL] [Abstract][Full Text] [Related]
28. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
[TBL] [Abstract][Full Text] [Related]
29. Newer insulin therapies for management of type 1 and type 2 diabetes mellitus.
Plum MB; Sicat BL; Brokaw DK
Consult Pharm; 2003 May; 18(5):454-65. PubMed ID: 16563061
[TBL] [Abstract][Full Text] [Related]
30. Long-term tolerability of inhaled human insulin (Exubera) in patients with poorly controlled type 2 diabetes.
Barnett AH; Lange P; Dreyer M; Serdarevic-Pehar M;
Int J Clin Pract; 2007 Oct; 61(10):1614-25. PubMed ID: 17877648
[TBL] [Abstract][Full Text] [Related]
31. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
32. An open, randomized, parallel-group study to compare the efficacy and safety profile of inhaled human insulin (Exubera) with glibenclamide as adjunctive therapy in patients with type 2 diabetes poorly controlled on metformin.
Barnett AH; Dreyer M; Lange P; Serdarevic-Pehar M
Diabetes Care; 2006 Aug; 29(8):1818-25. PubMed ID: 16873786
[TBL] [Abstract][Full Text] [Related]
33. Insulin glargine: long-acting basal insulin analog for improved metabolic control.
Gerich JE
Curr Med Res Opin; 2004 Jan; 20(1):31-7. PubMed ID: 14741069
[TBL] [Abstract][Full Text] [Related]
34. The pharmacokinetics and pharmacodynamics of rapid-acting insulin analogues and their clinical consequences.
Home PD
Diabetes Obes Metab; 2012 Sep; 14(9):780-8. PubMed ID: 22321739
[TBL] [Abstract][Full Text] [Related]
35. Safety and efficacy of inhaled human insulin (Exubera) during discontinuation and readministration of therapy in adults with type 1 diabetes: A 3-year randomized controlled trial.
Skyler JS; Hollander PA; Jovanovic L; Klioze S; Krasner A; Riese RJ; Reis J; Schwartz P; Duggan W;
Diabetes Res Clin Pract; 2008 Nov; 82(2):238-46. PubMed ID: 18824271
[TBL] [Abstract][Full Text] [Related]
36. Inhaled dry powder insulin for the treatment of diabetes mellitus.
Setter SM; Levien TL; Iltz JL; Odegard PS; Neumiller JJ; Baker DE; Campbell RK
Clin Ther; 2007 May; 29(5):795-813. PubMed ID: 17697900
[TBL] [Abstract][Full Text] [Related]
37. Insulin glargine.
Campbell RK; White JR; Levien T; Baker D
Clin Ther; 2001 Dec; 23(12):1938-57; discussion 1923. PubMed ID: 11813930
[TBL] [Abstract][Full Text] [Related]
38. Inhaled human insulin.
Strack TR
Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
[TBL] [Abstract][Full Text] [Related]
39. Inhaled insulin in diabetes mellitus.
Royle P; Waugh N; McAuley L; McIntyre L; Thomas S
Cochrane Database Syst Rev; 2003; (3):CD003890. PubMed ID: 12917994
[TBL] [Abstract][Full Text] [Related]
40. Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison.
Henry RR; Mudaliar S; Chu N; Kim D; Armstrong D; Davis TT; An B; Reinhardt RR
J Clin Pharmacol; 2003 Nov; 43(11):1228-34. PubMed ID: 14551177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]